Cg Oncology Inc (NASDAQ: CGON) on Tuesday, soared 3.16% from the previous trading day, before settling in for the closing price of $29.08. Within the past 52 weeks, CGON’s price has moved between $25.77 and $50.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -45.67% over the last five years. The company achieved an average annual earnings per share of -13.72%. With a float of $44.59 million, this company’s outstanding shares have now reached $67.54 million.
The firm has a total of 61 workers. Let’s measure their productivity. In terms of profitability, gross margin is 97.81%, operating margin of -13969.15%, and the pretax margin is -10578.22%.
Cg Oncology Inc (CGON) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cg Oncology Inc is 34.07%, while institutional ownership is 61.79%. The most recent insider transaction that took place on Jan 13 ’25, was worth 29,660. In this transaction Director of this company sold 1,000 shares at a rate of $29.66, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Director sold 700,000 for $28.00, making the entire transaction worth $19,600,000. This insider now owns 3,003,931 shares in total.
Cg Oncology Inc (CGON) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.72% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Cg Oncology Inc (CGON) is currently performing well based on its current performance indicators. A quick ratio of 35.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3358.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Analysing the last 5-days average volume posted by the [Cg Oncology Inc, CGON], we can find that recorded value of 0.74 million was better than the volume posted last year of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 38.25%. Additionally, its Average True Range was 1.58.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 22.27%, which indicates a significant decrease from 52.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.24% in the past 14 days, which was higher than the 48.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.03, while its 200-day Moving Average is $34.25. Now, the first resistance to watch is $30.48. This is followed by the second major resistance level at $30.96. The third major resistance level sits at $31.57. If the price goes on to break the first support level at $29.39, it is likely to go to the next support level at $28.78. Now, if the price goes above the second support level, the third support stands at $28.30.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
Market capitalization of the company is 2.28 billion based on 76,038K outstanding shares. Right now, sales total 200 K and income totals -48,610 K. The company made 40 K in profit during its latest quarter, and -20,410 K in sales during its previous quarter.
